Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iolanda M Fierro

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Brain, Behavior, and Immunity|December 1, 2009
Rotational stress-induced increase in epinephrine levels delays cutaneous wound healing in miceBruna Romana-Souza, Marcela Otranto, Andreza M Vieira, et al.
Nature Medicine|October 9, 2002
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptorMauro Perretti, Nan Chiang, Mylinh La, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cellsIolanda M Fierro, Sean P Colgan, Giovanni Bernasconi, et al.
Expert Opinion on Therapeutic Patents|August 31, 2016
Case study of patents related to captopril, Squibb's first blockbusterAdelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Jorge de Paula Costa Ávila, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileArndt J Schottelius, Claudia Giesen, Khusru Asadullah, et al.
Pharmaceutical Patent Analyst|December 10, 2014
Nanoparticles applied to antineoplastic agents: a patent landscapeIolanda M Fierro, Maria Simone de Menezes Alencar, Flavia Maria Lins Mendes, et al.
American Journal of Respiratory Cell and Molecular Biology|July 16, 2013
Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analogRafael F Guilherme, Debora G Xisto, Steven L Kunkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in miceDanielle G Souza, Caio T Fagundes, Flavio A Amaral, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosisVanessa Martins, Samuel S Valença, Francisco A Farias-Filho, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Brain, Behavior, and Immunity|December 1, 2009
Rotational stress-induced increase in epinephrine levels delays cutaneous wound healing in miceBruna Romana-Souza, Marcela Otranto, Andreza M Vieira, et al.
Nature Medicine|October 9, 2002
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptorMauro Perretti, Nan Chiang, Mylinh La, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cellsIolanda M Fierro, Sean P Colgan, Giovanni Bernasconi, et al.
Expert Opinion on Therapeutic Patents|August 31, 2016
Case study of patents related to captopril, Squibb's first blockbusterAdelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Jorge de Paula Costa Ávila, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileArndt J Schottelius, Claudia Giesen, Khusru Asadullah, et al.
Pharmaceutical Patent Analyst|December 10, 2014
Nanoparticles applied to antineoplastic agents: a patent landscapeIolanda M Fierro, Maria Simone de Menezes Alencar, Flavia Maria Lins Mendes, et al.
American Journal of Respiratory Cell and Molecular Biology|July 16, 2013
Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analogRafael F Guilherme, Debora G Xisto, Steven L Kunkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in miceDanielle G Souza, Caio T Fagundes, Flavio A Amaral, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosisVanessa Martins, Samuel S Valença, Francisco A Farias-Filho, et al.
Pageof 2